Article

Mmarketwatch.com on 2019-10-28 14:30

Centogene to offer 4 million shares in planned IPO priced at $14 to $16 each

Centogene set terms for its planned initial public offering on Monday, saying it plans to offer 4 million shares priced at $14 to $16 each. The biotech,...

Related news

MLyra Therapeutics to offer 3.5 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MProgenity to offer 6.7 million shares in planned IPO priced at $14 to $16 each marketwatch.com
MBiotech Inhibrx to offer 6 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MBiotech Alzheon to offer 6 million shares in planned IPO priced at $4 to $6 each marketwatch.com
MTrevi Therapeutics to offer 6.7 million shares in planned IPO priced at $14 to $16 each marketwatch.com
Needham
MBiotech Oncorus to offer 5.8 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MPandion Therapeutics to offer 5.5 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MSurveyMonkey to offer 13.5 million shares in planned IPO, priced at $9 to $11 each marketwatch.com
MIGM Biosciences to offer 7.8 million shares in planned IPO, priced at $15 to $17 each marketwatch.com
MGreenwich LifeSciences to offer 1 mln shares in planned IPO, priced at $7.50 to $8.50 each marketwatch.com
MOutset Medical to offer 7.6 million shares in planned IPO, priced at $22 to $24 each marketwatch.com
Outset
MPandion Therapeutics upsizes planned IPO, to offer 7 million shares priced at $16 to $18 each marketwatch.com
MParsons Corp. to offer 18.5 million shares in planned IPO priced at $26 to $28 each marketwatch.com
MZoomInfo Technologies to offer 44.5 million shares in planned IPO priced at $16 to $18 each marketwatch.com
MGoHealth to offer 39.5 million shares in planned IPO, priced at $18 to $20 each marketwatch.com
MAnnexon to offer 10 million shares in planned IPO priced at $14 to $16 each marketwatch.com
MADC Therapeutics to offer 8.1 million shares in planned IPO, priced at $23 to $26 each marketwatch.com
MAssetMark Financial to offer 12.5 million shares in planned IPO, priced at $19 to $21 each marketwatch.com
MRapt Therapeutics to offer 3 million shares in planned IPO priced at $12 to $14 each marketwatch.com
MBeam Therapeutics to offer 6.25 million shares in planned IPO priced at $15 to $17 each marketwatch.com